"The Company will provide a video on its website of the events, which will be covered by the print, internet and television media so that the entire world can see with its own eyes the importance of accurate signal detection," added AFL Founder, World-Class sprinter, Gold Medal Winner, and Super Bowl winner, Willie Gault.
AFL plans to have several additional members join as founders in preparation for these events, and Signalife will announce these superstars as they are signed. In California, track and screening locations have already been identified in Orange, Los Angeles, San Bernardino and San Francisco Counties and the public will be invited to meet the celebrity athletes -- and other celebrities -- within two weeks of each event.
AFL exclusively uses Signalife's Fidelity 100 for coronary testing, because the Signalife device is the only one able to detect the presence of coronary artery disease in an ambulatory environment, and for other reasons. Signalife is providing dozens of devices for the first series of events, at reduced price points for the AFL 501 (c)(3) charity.
For more information, please contact Signalife's corporate offices; however, the company will issue additional press releases as each event approaches.
Signalife, Inc. is a life sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Signalife uses its patented signal technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting.
Signalife is publicly traded on the American Stock Exchange under the symbol SGN. The website for the company is http://Signalife.com. Clear Data. Trusted Results.
Caution Regarding Forward-Looking Statements:
Statements in this release that are not strictly historical are
|SOURCE Signalife, Inc.|
Copyright©2007 PR Newswire.
All rights reserved